medigraphic.com
Órgano Oficial de la Asociación Mexicana de Infectología Pediátrica y la SLIPE.

2006, Number 77

<< Back

Rev Enfer Infec Pediatr 2006; 19.20 (77)

Effectiveness of a ribosomal inmunoestimulante in the prevention of respiratory infections in prescholastic population of the city of Orizaba, Veracruz

Varela CM, Lara AV, Martínez BA, Romero BM, Pérez VNC, Cruz PMF, Salcedo BC

Language: Spanish
References: 20
Page: 17-23
PDF size: 152.72 Kb.


ABSTRACT

Antecedents. The respiratory infections in children who attend day-care centers and schools are a problem of public health by the infect recurrent derivative of the lack of suitable measures of prevention and inefficiency of the prescribed treatments.
Objective. To study and to evaluate the effectiveness of a immunoestimulant formed by ribosomales fractions of: Haemophilus influenzae, Sptreptoccocus pneumoniae, Streptococcus pyogenes and Klebsiella pneumoniae that favors the immunological protection and stimulates the defense mechanisms.
Patients and method: 94 patients who divided themselves in two groups (A and B) assigned at random, of prospective, longitudinal and comparative way studied. The patients of the group A received the immunoestimulant and those of group B were the group control (they did not receive the immunoestimulant).
Results. Was both a noticeable difference with statistical meaning between groups. The patients who received the immunoestimulant had favorable effects, like: diminution of the frequency and intensity of the respiratory infections, less episodes of disease and less days with the same one, less days of fever and treatment with antibiotic and greater resistance to the infect due to the stimulation of the specific and non specific immunity.
Conclusions. The prevention of respiratory infections in the children is a measurement desirable and necessary to diminish the incidence and prevalence of the same ones. One of the resources that are demonstrated to effectiveness in the diminution of the episodes and duration of such is the prevention with the immunoestimulant Ribovac.


REFERENCES

  1. Metchnikoff E. Immunity in the infectious diseases. 1st ed. New York: MacMillan Press, 1905.

  2. Silverstein AM. History of immunology. 1st ed. London: Academic Press, 1989.

  3. Reporte de mortalidad. Ginebra: OMS, 2004. Eficacia de un inmunoestimulante ribosomal en la prevención de infecciones respiratorias en población preescolar de la ciudad de Orizaba, Veracruz 23

  4. Informe de mortalidad. México: Secretaría de Salud, 2002.

  5. Schwartz B, Giebink GS, Henderson FW, et al. Respiratory infections in day care. Pediatrics 1994;94:1018.

  6. Immunogenic Activity of Ribosomal Fraction Obtained from Mycobacterium tuberculosis. J Bacteriology 1965;89(5).

  7. Fiocchi A, Arancio R, Cinquepalmi P, et al. Recurrent respiratory infections in childhood: Experience with a bacterial extract plus bacterial ribosomes (Immucytal). J Int Med Res 1990;18:50.

  8. Puigdoltiers JM, Rodesserba G, Hernández del Rey l, et al. Immunoglubulin production in man stimulated by orally administered bacterial lysate (Broncho-Vaxom). Respiration 1980;40:142.

  9. Fiocchi A, Giovannini M. Clinical evaluation of ribosomal immunotherapy in recurrent respiratory infections: Results of a meta-analysis. Drugs 1997;54(suppl. 1): 45.

  10. Fontanges R, Robert D, Content Y, et al. Pouvoir vaccinant de ribosomes extraits de K. pneumoniae, S. pneumoniae, S. pyogenes et H. influenzae et d` une fraction membranaire de K. pneumoniae. Rev Fr Allergol Immonol Clin 1977;17:35-81.

  11. Faure G, Bène MC, Simon C, et al. Increase in specific antibody-forming cells in human tonsils after oral stimulation with D-53, a ribosomal vaccines. Int J Immunopharm 1990;12:315-20.

  12. Zanin C, Perrin P, Bène MC, et al. Antibody-production cells in peripheral blood and tonsils after oral treatment of children with bacterial ribosomes. Int J Immunopharm 1994;16:497-505.

  13. Hbabi-Haddioui L, Roques C. Inhibition of Streptococcus pneumoniae adhesion by specific salivary IgA after oral immunization with a ribosomal immunostimulant. Drugs 1997;54 (Suppl. 1):29-32.

  14. Castañeda JL, Chávez Rodríguez. Estudio de eficacia de un tratamiento preventivo de 3 meses de duración con derivados ribosomales en niños con infección respiratoria recurrente que asisten a guardería. Rev Enf Infec Ped 2002;15:60.

  15. Dussourd D, Hinterland L, Pinel AM, Rey G. Immunological study. Arzneimittelforschumg 1980;30:132-41.

  16. Fontanges R, Binder P, Burckhart MF. Etude en microscopie électronique de balayage et de transmission des modifications morphologiques des macrophages péritonéaux de la souris Bald/C après stimulation locale par D 53. Rev Fr d’Allergol 1981;21:227-31.

  17. Bènè MC, Kahl L, Perruchet AM, et al. Bacterial lysates and ribosomes as inducers of specific immune responses: a comparative study. Scand J Immunol 1993;38:496-9.

  18. Zanin C, Perrin P, Bènè MC, et al. Antibody-producing cells in peripheral blood and tonsils after oral treatment of children with bacterial ribosomes. Int J Immunopharmacol 1994;16:497-505.

  19. Mufson MA. Streptococcus pneumoniae. In: Mandell GL, Douglas RG, Bennett JE, editors. Principles and practice of infectious diseases. 3th ed. New York: Churchill Livingstone, 1990; pp:1539-50.

  20. Mond JJ, Lees A, Snapper CM. T cell-independent antigens type 2. Annu Rev Immunol 1995;13:655-92.




2020     |     www.medigraphic.com